Breast Neoplasms: all 12,820 studies

Page 36 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• Exercise Program in Cancer and CognitionCompletedNCT02793921Not applicableResults posted
• Neoadjuvant Therapy in Clinical Stage I-III HER2-positive Breast Cancer.CompletedNCT02789657Phase 2Results posted
• Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast CancerActive, not recruitingNCT02788981Phase 2Results posted
• A Study of LY3039478 in Participants With Advanced or Metastatic Solid TumorsTerminatedNCT02784795Phase 1Results posted
• A Trial of 15 Fraction vs 25 Fraction Pencil Beam Scanning Proton Radiotherapy After Mastectomy in Patients Requiring Regional Nodal IrradiationCompletedNCT02783690Phase 2Results posted
• Increasing Physical Activity Among Breast Cancer Survivors With DepressionCompletedNCT02781051Not applicableResults posted
• A Study to Assess the Pharmacokinetics and Safety of Different Forms and Formulations of AZD9496 in Healthy SubjectsCompletedNCT02780713Phase 1Results posted
• Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in RemissionCompletedNCT02780401Phase 1Results posted
• Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast CancerCompletedNCT02779855Phase 1/2Results posted
• Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast CancerActive, not recruitingNCT02778685Phase 2Results posted
• Study of Cirmtuzumab and Paclitaxel for Metastatic or Locally Advanced, Unresectable Breast CancerCompletedNCT02776917Phase 1Results posted
• Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain MetastasisTerminatedNCT02774681Phase 2Results posted
• A Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 (+) Breast Cancer Who Have Completed the SB3-G31-BCTerminatedNCT02771795Results posted
• Study Of Single-dose Cyclophosphamide +Pembrolizumab In Patients With Metastatic Triple Negative Breast CancerCompletedNCT02768701Phase 2Results posted
• Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)Active, not recruitingNCT02764541Phase 2Results posted
• A Study of Abemaciclib (LY2835219) in Participants With Breast CancerActive, not recruitingNCT02763566Phase 3Results posted
• Sapanisertib in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor TherapyCompletedNCT02756364Phase 2Results posted
• Pilot Study for a Prospective Surveillance Program for Rehabilitation Following Surgery for Breast CancerCompletedNCT02754427Not applicableResults posted
• Study of Eribulin Mesylate in Combination With PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer (MBC)TerminatedNCT02753595Phase 1/2Results posted
• Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast CancerActive, not recruitingNCT02752685Phase 2Results posted
• QUILT-3.013: Study of Ad5 [E1-, E2b-]-HER2/Neu Vaccine (ETBX-021) in Subjects With Unresectable Locally Advanced or Metastatic HER2-Expressing Breast CancerTerminatedNCT02751528Phase 1Results posted
• A Study of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Advanced and/or Metastatic Breast CancerCompletedNCT02748213Phase 2Results posted
• A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast CancerCompletedNCT02747004Phase 2Results posted
• Standard of Care Chemotherapy Plus Pembrolizumab for Breast CancerActive, not recruitingNCT02734290Phase 1/2Results posted
• A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.Active, not recruitingNCT02734004Phase 1/2Results posted
• Study of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Cancer Post Progression on CDK 4/6 Inhibitor.CompletedNCT02732119Phase 1/2Results posted
• Study to Assess the Efficacy of Pembrolizumab Plus Radiotherapy in Metastatic Triple Negative Breast Cancer PatientsCompletedNCT02730130Phase 2Results posted
• Pilot Study of the Effect of Duavee® on Benign Breast Tissue ProliferationCompletedNCT02729701Phase 2Results posted
• S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)CompletedNCT02728596Not applicableResults posted
• MRI-Based Preoperative Accelerated Partial Breast IrradiationActive, not recruitingNCT02728076Not applicableResults posted
• Pilot Study of an Intimacy Enhancement Intervention for Couples Facing Breast CancerCompletedNCT02721147Not applicableResults posted
• Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFRTerminatedNCT02720185Phase 2Results posted
• Phase I Study of MLN0128 and MLN8237 in Patients With Advanced Solid Tumors and Metastatic Triple-negative Breast CancerCompletedNCT02719691Phase 1Results posted
• Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast CancerActive, not recruitingNCT02712723Phase 2Results posted
• Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesTerminatedNCT02711137Phase 1/2Results posted
• Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead InCompletedNCT02708680Phase 1/2Results posted
• Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ MalignanciesTerminatedNCT02706392Phase 1Results posted
• Shorter Course Radiation for the Treatment of Breast Cancer That Has Spread to Lymph NodesCompletedNCT02700386Phase 2Results posted
• eHealth Weight Loss Program in African American Breast Cancer SurvivorsCompletedNCT02699983Not applicableResults posted
• Avoiding Growth Factor During Paclitaxel Treatment in Breast CancerCompletedNCT02698891Phase 2Results posted
• Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast CancerTerminatedNCT02696759Not applicableResults posted
• An Integrated Consent Model Study to Compare Two Standard of Care Schedules for Monitoring Cardiac Function in Patients Receiving Trastuzumab for Early Stage Breast CancerCompletedNCT02696707Phase 4Results posted
• Peers Promoting Exercise Adoption and Maintenance Among Cancer SurvivorsCompletedNCT02694640Not applicableResults posted
• Active Breathing Coordinator-based vs VisionRT-based Deep Inspiration Breath-hold for Radiation for Breast CancerCompletedNCT02694029Not applicableResults posted
• Palbociclib / Letrozole or Fulvestrant in African American Women With HR+ HER2- Breast CancerCompletedNCT02692755Phase 2/3Results posted
• A Multi-Reader Multi-Case Pivotal TrialCompletedNCT02692209Results posted
• Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast CancerCompletedNCT02689427Phase 2Results posted
• Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the Neoadjuvant/Adjuvant Setting (REaCT-TNBC)TerminatedNCT02688803Phase 4Results posted
• Study to Evaluate the Safety, Biodistribution, Radiation Dosimetry and Tumor Imaging Potential of [131I]-SGMIB Anti-HER2 VHH1 in Healthy Volunteers and Breast Cancer PatientsCompletedNCT02683083Phase 1Results posted
• ALERT: A Phase II Study of Alternating Eribulin and Hormonal Therapy in Pre-treated ER+ve Breast Cancer.TerminatedNCT02681523Phase 2Results posted
• Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast CancerCompletedNCT02679755Phase 4Results posted
• 99mTc-rhAnnexin V-128 Imaging and Cardiotoxicity in Patients With Early Breast CancerTerminatedNCT02677714Phase 2Results posted
• A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast CancerCompletedNCT02675231Phase 2Results posted
• STOP Heart Disease in Breast Cancer Survivors TrialTerminatedNCT02674204Phase 2Results posted
• The Breast Cancer Online Rehabilitation ProgramCompletedNCT02673918Not applicableResults posted
• Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast CancerCompletedNCT02673398Phase 2Results posted
• MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived TumorsTerminatedNCT02669914Phase 2Results posted
• Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast CancerCompletedNCT02668666Phase 2Results posted
• Reproductive Health Survivorship Care PlanCompletedNCT02667626Not applicableResults posted
• Study of Poziotinib in Participants With HER2-Positive Metastatic Breast CancerCompletedNCT02659514Phase 2Results posted
• Talimogene Laherparepvec in Treating Patients With Recurrent Breast Cancer That Cannot Be Removed by SurgeryTerminatedNCT02658812Phase 2Results posted
• A Study of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer Who Have Received Prior Treatment With Trastuzumab and a TaxaneCompletedNCT02658734Phase 4Results posted
• An Observational Time and Motion Study of Trastuzumab Subcutaneous (SC) and Intravenous (IV) Formulations in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (EBC)CompletedNCT02658461Results posted
• Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast CancerTerminatedNCT02658084Phase 1/2Results posted
• Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian CancerCompletedNCT02657889Phase 1/2Results posted
• An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer.CompletedNCT02657343Phase 1/2Results posted
• Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After SurgeryCompletedNCT02654119Phase 2Results posted
• A Study Of The Safety And Effects Of One Or More Doses Of HSP-130 Injected Under The Skin In Women With Breast Cancer That Has Not Spread To Distant Sites In The Body.CompletedNCT02650193Phase 2Results posted
• Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast CancerCompletedNCT02648477Phase 2Results posted
• Assessment of Periodic Screening of Women With Denser Breast Using WBUS and DBTCompletedNCT02643966Not applicableResults posted
• SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE)CompletedNCT02643420Phase 3Results posted
• Aging Mammary Stem Cells and Breast Cancer PreventionTerminatedNCT02642094Phase 2Results posted
• Topical Cryotherapy in Reducing Pain in Patients With Chemotherapy Induced Peripheral Neuropathy or Paclitaxel Induced Acute Pain SyndromeCompletedNCT02640053Not applicableResults posted
• Magnetic Seed Localisation of Breast CancersCompletedNCT02635737Not applicableResults posted
• Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast CancerCompletedNCT02632045Phase 2Results posted
• Two Different Schedules of Palbociclib + Second Line Endocrine Therapy in Estrogen Receptor Positive, HER2 Neg Advanced/Metastatic Breast CancerCompletedNCT02630693Phase 2Results posted
• 2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast CancerTerminatedNCT02624700Phase 2Results posted
• Safety and Efficacy Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy as Neoadjuvant Treatment for Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-173/KEYNOTE-173)CompletedNCT02622074Phase 1Results posted
• A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast CancerCompletedNCT02614794Phase 2Results posted
• A Study to Develop Predictive and Prognostic Tools for Optimizing Therapy With Bevacizumab Frontline Cancer Therapy in Participants With HER 2-Negative Aggressive Metastatic Breast CancerCompletedNCT02613208Results posted
• Effectiveness of Fluoroscopy-guided MLD for Treatment of BCRLCompletedNCT02609724Not applicableResults posted
• Tactile Breast Imaging Sensor for Tumor Malignancy CharacterizationCompletedNCT02603211Results posted
• Palbociclib Plus Letrozole For Postmenopausal Women With HR(+) HER2(-) Advanced Breast Cancer For Whom Letrozole Is Deemed AppropriateCompletedNCT02600923Phase 3Results posted
• 18F-FSPG PET/CT for Cancer Patients on TherapyCompletedNCT02599194Phase 2Results posted
• Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast CancerCompletedNCT02598557Phase 2Results posted
• Clinical Utility Study of a Low-Cost Hand-Held Breast ScannerCompletedNCT02597452Not applicableResults posted
• Neoadjuvant Propanolol in Breast CancerTerminatedNCT02596867Phase 2Results posted
• Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain MetastasesCompletedNCT02595905Phase 2Results posted
• Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant ChemotherapyCompletedNCT02595372Phase 2Results posted
• Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBCCompletedNCT02593175Phase 2Results posted
• TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast CancerCompletedNCT02586675Phase 1Results posted
• Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer to Evaluate Treatment With Trastuzumab Plus (+) Pertuzumab + Docetaxel Compared With Trastuzumab + Placebo + DocetaxelCompletedNCT02586025Phase 3Results posted
• Treatment of Brain Metastases From Breast Cancer With Eribulin MesylateCompletedNCT02581839Phase 2Results posted
• Study of Human Epidermal Growth Receptor (HER2) Status Evaluation in Breast Cancer Pathology SamplesCompletedNCT02580799Results posted
• Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC)CompletedNCT02574455Phase 3Results posted
• A Study of GDC-0810 Versus Fulvestrant in Postmenopausal Women With Advanced or Metastatic Breast Cancer Resistant to Aromatase Inhibitor (AI) TherapyTerminatedNCT02569801Phase 2Results posted
• Brain Irradiation and Tremelimumab in Metastatic Breast CancerCompletedNCT02563925Not applicableResults posted
• T-DM1 and Non-pegylated Liposomal Doxorubicin in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast CancerCompletedNCT02562378Phase 1Results posted
• A Phase I, Open-Label, 2 Part Multicentre Study to Assess the Safety and Efficacy of Olaparib in Combination With Carboplatin in Patients With Advanced HER-2 Negative Breast CancerTerminatedNCT02561832Phase 1Results posted
• Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast CancerCompletedNCT02556632Phase 2Results posted

← Breast Neoplasms overview